{"gene":"ZCCHC8","run_date":"2026-06-11T09:02:06","timeline":{"discoveries":[{"year":2018,"finding":"Crystal structure of the ZCCHC8 C-terminal domain bound to the MTR4 helicase core reveals a bipartite interaction that is distinct from yeast exosome cofactors Trf4p/Air2p; this interaction stimulates MTR4 helicase and ATPase activities. RBM7 association with NEXT further enhances MTR4 helicase activity, with uridine-rich substrates preferred by RBM7 and polyadenylated 3' ends optimal for full activity.","method":"Crystal structure determination, in vitro helicase/ATPase assays, domain mapping, mutagenesis","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1 / Strong — crystal structure combined with in vitro reconstituted enzymatic assays and mutagenesis in a single rigorous study","pmids":["29844170"],"is_preprint":false},{"year":2016,"finding":"A proline-rich segment of ZCCHC8 serves as the direct interaction site for the RNA-recognition motif (RRM) of RBM7, as revealed by crystal structure at 2.0 Å resolution, defining how RBM7 is incorporated into the NEXT complex. The same ZCCHC8 proline-rich motif shares structural similarity with splicing factor SAP145, allowing RBM7 to interact with both NEXT and spliceosomal components.","method":"Crystal structure (2.0 Å), domain mapping, in vitro binding assays","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 1 / Strong — high-resolution crystal structure with functional domain mapping, replicated across two orthogonal binding assays in the same study","pmids":["27905398"],"is_preprint":false},{"year":2019,"finding":"ZCCHC8 associates with telomerase RNA (TR) and is required for its 3' end maturation; loss of ZCCHC8 causes accumulation of genomically extended TR at the expense of mature TR, consistent with a role in mediating TR 3' end targeting to the nuclear RNA exosome. Heterozygous loss-of-function of ZCCHC8 causes TR insufficiency in both human mutation carriers and heterozygous Zcchc8-null mice.","method":"Genome-wide linkage, ZCCHC8 knockout cells, Zcchc8-null mouse model, RNA analysis (TR maturation), association studies","journal":"Genes & development","confidence":"High","confidence_rationale":"Tier 2 / Strong — reciprocal genetic and molecular evidence across human patients and mouse KO model with orthogonal RNA maturation assays","pmids":["31488579"],"is_preprint":false},{"year":2019,"finding":"Zcchc8-null mice show accumulation and 3' end misprocessing of low-abundance RNAs including intronless replication-dependent histone mRNAs and cilia-component RNAs, demonstrating that nuclear exosome targeting via ZCCHC8 is an essential 3' end maturation mechanism shared across these RNA classes.","method":"Zcchc8-null mouse model, transcriptome analysis, RNA 3' end sequencing","journal":"Genes & development","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — KO mouse with defined transcriptomic phenotype, single lab, RNA-seq as primary readout","pmids":["31488579"],"is_preprint":false},{"year":2019,"finding":"Zcchc8 is required for degradation of LINE1 retrotransposon transcripts in mouse early embryos and embryonic stem cells; Zcchc8-deficient ESCs exhibit proliferation abnormalities and reduced developmental potency, and maternal Zcchc8-depleted oocytes show higher chromatin accessibility and developmental defects, establishing a Zcchc8-mediated RNA degradation mechanism targeting LINE1.","method":"Zcchc8 knockout mouse, ESC depletion, RNA quantification, chromatin accessibility assays, developmental phenotyping","journal":"Cell reports","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — clean KO with defined cellular and molecular phenotype, single lab, multiple orthogonal readouts","pmids":["31747613"],"is_preprint":false},{"year":2005,"finding":"Zcchc8 is directly phosphorylated by GSK-3 in vitro, and GSK-3 inhibition prevents Zcchc8 phosphorylation in vivo. Zcchc8 is a nuclear protein that interacts with RNA processing/degradation proteins.","method":"In vitro kinase assay with GSK-3, GSK-3 inhibitor treatment in cells, immunoprecipitation with RNA-binding proteins","journal":"Biochemical and biophysical research communications","confidence":"Medium","confidence_rationale":"Tier 1–2 / Moderate — in vitro kinase assay plus cellular inhibitor validation plus co-IP, single lab, early foundational study","pmids":["16263084"],"is_preprint":false},{"year":2024,"finding":"A novel ZCCHC8 mutation (p.P410A) disrupts nucleocytoplasmic localization of ZCCHC8, which further decreases expression of DKC1 and RTEL1 and reduces telomere length, linking ZCCHC8 nuclear localization to telomere maintenance.","method":"Whole exome sequencing, Sanger sequencing, subcellular localization assay, gene expression analysis, telomere length measurement","journal":"Molecular medicine (Cambridge, Mass.)","confidence":"Medium","confidence_rationale":"Tier 2–3 / Weak — localization assay with functional downstream readouts, single lab, single family","pmids":["39256642"],"is_preprint":false},{"year":2024,"finding":"Loss of ZCCHC8 during spermatogenesis results in upregulation of young LINE1 (L1Md_A) subfamilies in spermatogonial stem cells and pachytene spermatocytes, accompanied by reduced H3K9me3 in SSC and elevated H3K4me3 in pachytene spermatocytes at L1 loci, contributing to impaired chromatin condensation and delayed meiotic progression.","method":"Zcchc8 knockout mouse, RNA-seq, ChIP-seq for H3K9me3 and H3K4me3, spermatogenesis phenotyping","journal":"National science review","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — KO mouse with ChIP-seq and RNA-seq defining chromatin mechanism, single lab","pmids":["39758125"],"is_preprint":false},{"year":2025,"finding":"Chromatin recruitment mapping shows ZCCHC8 (NEXT) associates with sites of enhancer-promoter interactions. Depletion of NEXT induces accumulation of ncRNAs (eRNAs and PROMPTs) and increases cohesin levels at those sites, suggesting NEXT-mediated ncRNA degradation influences cohesin binding and 3D enhancer-promoter contacts.","method":"ChIP-seq (chromatin recruitment), NEXT depletion, RNA-seq, chromatin conformation capture (3C/Hi-C)","journal":"bioRxiv","confidence":"Low","confidence_rationale":"Tier 3 / Weak — preprint, single lab, indirect evidence linking ZCCHC8 chromatin localization to cohesin/3D genome; primary focus is MTR4 rather than ZCCHC8 specifically","pmids":["bio_10.1101_2025.08.25.671287"],"is_preprint":true}],"current_model":"ZCCHC8 is a scaffold zinc-knuckle protein that forms the NEXT (nuclear exosome targeting) complex with RBM7 and MTR4, where it bridges RBM7 (via a proline-rich domain) and directly stimulates MTR4 helicase/ATPase activity through its C-terminal domain, thereby targeting aberrant and noncoding RNAs—including telomerase RNA, replication-dependent histone mRNAs, and LINE1 retrotransposon transcripts—for 3' end maturation or degradation by the nuclear RNA exosome; its nuclear localization is functionally required, as disease-associated mutations disrupt this localization and impair telomere maintenance, and it is also a substrate of GSK-3 kinase."},"narrative":{"mechanistic_narrative":"ZCCHC8 is the scaffold subunit of the nuclear exosome targeting (NEXT) complex, coupling RNA substrate recognition to the catalytic machinery that degrades or matures aberrant and noncoding nuclear RNAs [PMID:29844170, PMID:27905398]. A proline-rich segment of ZCCHC8 directly engages the RNA-recognition motif of RBM7, incorporating it into NEXT, while structural mimicry of the splicing factor SAP145 by this motif allows RBM7 to partition between NEXT and spliceosomal components [PMID:27905398]. Through a bipartite C-terminal interaction with the MTR4 helicase core, ZCCHC8 directly stimulates MTR4 helicase and ATPase activities, with RBM7 association further enhancing activity on uridine-rich and polyadenylated substrates [PMID:29844170]. Functionally, ZCCHC8 directs 3' end maturation and degradation of diverse RNA classes by the nuclear RNA exosome, including telomerase RNA, intronless replication-dependent histone mRNAs, and LINE1 retrotransposon transcripts [PMID:31488579, PMID:31747613]. Loss of ZCCHC8 causes accumulation of genomically extended telomerase RNA at the expense of mature TR, and heterozygous loss-of-function produces TR insufficiency in human carriers and mice [PMID:31488579]; a localization-disrupting mutation lowers DKC1 and RTEL1 expression and shortens telomeres, linking ZCCHC8 nuclear localization to telomere maintenance [PMID:39256642]. Beyond RNA turnover, ZCCHC8-mediated LINE1 degradation shapes the chromatin landscape during early development and spermatogenesis [PMID:31747613, PMID:39758125], and ZCCHC8 is directly phosphorylated by GSK-3 [PMID:16263084].","teleology":[{"year":2005,"claim":"Established ZCCHC8 as a nuclear protein physically associated with RNA processing/degradation machinery and a direct kinase substrate, providing the first functional context before NEXT was defined.","evidence":"In vitro GSK-3 kinase assay, cellular GSK-3 inhibition, and co-IP with RNA-binding proteins","pmids":["16263084"],"confidence":"Medium","gaps":["Specific phosphosites and the functional consequence of GSK-3 phosphorylation not defined","Identity of the associated RNA-processing partners not resolved at molecular level"]},{"year":2016,"claim":"Resolved how RBM7 is recruited into NEXT, showing ZCCHC8 acts as the structural bridge for substrate-recognition subunits.","evidence":"2.0 Å crystal structure of the ZCCHC8 proline-rich segment bound to the RBM7 RRM, with domain mapping and in vitro binding","pmids":["27905398"],"confidence":"High","gaps":["Does not address how the assembled complex selects in vivo RNA substrates","Functional consequence of the SAP145 mimicry / spliceosome crosstalk not tested in cells"]},{"year":2018,"claim":"Defined the catalytic coupling of NEXT, showing ZCCHC8 directly activates the exosome helicase rather than merely tethering it.","evidence":"Crystal structure of the ZCCHC8 C-terminal domain bound to the MTR4 helicase core, with reconstituted in vitro helicase/ATPase assays and mutagenesis","pmids":["29844170"],"confidence":"High","gaps":["In vitro substrate preferences may not capture full physiological substrate range","How ZCCHC8 stimulation is regulated in the cell is unknown"]},{"year":2019,"claim":"Connected the molecular machinery to physiology, establishing ZCCHC8 as required for telomerase RNA 3' end maturation and as a disease-relevant cause of TR insufficiency.","evidence":"Human linkage/mutation carriers, Zcchc8-null mice, knockout cells, and RNA maturation assays","pmids":["31488579"],"confidence":"High","gaps":["Mechanism by which extended TR is selectively recognized vs other substrates not dissected","Clinical penetrance/spectrum from heterozygous loss not fully mapped"]},{"year":2019,"claim":"Generalized ZCCHC8 function beyond telomerase RNA, showing it mediates 3' end processing of multiple low-abundance RNA classes.","evidence":"Zcchc8-null mouse transcriptome and RNA 3' end sequencing of histone and cilia-component RNAs","pmids":["31488579"],"confidence":"Medium","gaps":["Single-lab transcriptomic readout","Direct vs indirect effects on each RNA class not separated"]},{"year":2019,"claim":"Identified a developmental role through targeted degradation of LINE1 transcripts, linking RNA surveillance to chromatin state and developmental potency.","evidence":"Zcchc8 knockout mice, ESC depletion, RNA quantification, chromatin accessibility assays, developmental phenotyping","pmids":["31747613"],"confidence":"Medium","gaps":["Whether LINE1 effects are entirely exosome-dependent not established","Single-lab phenotype"]},{"year":2024,"claim":"Demonstrated that nuclear localization of ZCCHC8 is functionally required for telomere maintenance, tying a specific mutation to downstream telomere-pathway gene expression.","evidence":"Whole exome/Sanger sequencing of a family, subcellular localization assay, DKC1/RTEL1 expression and telomere length measurement","pmids":["39256642"],"confidence":"Medium","gaps":["Single family, single lab","Mechanism linking mislocalization to reduced DKC1/RTEL1 expression unresolved"]},{"year":2024,"claim":"Extended the LINE1-surveillance role to meiosis, showing ZCCHC8 loss derepresses young LINE1 and alters histone marks, impairing spermatogenesis.","evidence":"Zcchc8 knockout mouse, RNA-seq, ChIP-seq for H3K9me3 and H3K4me3, spermatogenesis phenotyping","pmids":["39758125"],"confidence":"Medium","gaps":["Causal link between RNA derepression and the observed histone changes not fully separated","Single-lab study"]},{"year":2025,"claim":"Proposed a role for NEXT/ZCCHC8 in 3D genome organization via ncRNA degradation affecting cohesin and enhancer-promoter contacts.","evidence":"ChIP-seq chromatin recruitment, NEXT depletion with RNA-seq, and chromatin conformation capture (preprint)","pmids":["bio_10.1101_2025.08.25.671287"],"confidence":"Low","gaps":["Preprint, not peer-reviewed; primary focus on MTR4 rather than ZCCHC8","Indirect link between ncRNA degradation and cohesin/3D contacts","ZCCHC8-specific contribution not isolated"]},{"year":null,"claim":"How ZCCHC8 substrate selectivity is governed across its diverse RNA targets, and how post-translational regulation (e.g. GSK-3 phosphorylation) and chromatin recruitment integrate with NEXT activity, remain open.","evidence":"","pmids":[],"confidence":"Low","gaps":["No unified model of substrate discrimination among TR, histone mRNAs, and LINE1","Functional consequence of GSK-3 phosphorylation undefined","Chromatin-recruitment mechanism unconfirmed in peer-reviewed work"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0003723","term_label":"RNA binding","supporting_discovery_ids":[0,2,5]},{"term_id":"GO:0060090","term_label":"molecular adaptor activity","supporting_discovery_ids":[0,1]},{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[0]}],"localization":[{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[5,6]},{"term_id":"GO:0005694","term_label":"chromosome","supporting_discovery_ids":[7]}],"pathway":[{"term_id":"R-HSA-8953854","term_label":"Metabolism of RNA","supporting_discovery_ids":[0,2,3,4]}],"complexes":["NEXT (nuclear exosome targeting) complex"],"partners":["RBM7","MTR4","GSK-3"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"Q6NZY4","full_name":"Zinc finger CCHC domain-containing protein 8","aliases":["TRAMP-like complex RNA-binding factor ZCCHC8"],"length_aa":707,"mass_kda":78.6,"function":"Scaffolding subunit of the trimeric nuclear exosome targeting (NEXT) complex that is involved in the surveillance and turnover of aberrant transcripts and non-coding RNAs (PubMed:27871484). NEXT functions as an RNA exosome cofactor that directs a subset of non-coding short-lived RNAs for exosomal degradation. May be involved in pre-mRNA splicing (Probable). It is required for 3'-end maturation of telomerase RNA component (TERC), TERC 3'-end targeting to the nuclear RNA exosome, and for telomerase function (PubMed:31488579)","subcellular_location":"Nucleus, nucleoplasm; Nucleus","url":"https://www.uniprot.org/uniprotkb/Q6NZY4/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/ZCCHC8","classification":"Not Classified","n_dependent_lines":2,"n_total_lines":77,"dependency_fraction":0.025974025974025976},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[{"gene":"SNRPA","stoichiometry":10.0},{"gene":"SSRP1","stoichiometry":10.0},{"gene":"CPSF6","stoichiometry":4.0},{"gene":"DDX21","stoichiometry":0.2},{"gene":"DHX9","stoichiometry":0.2},{"gene":"HNRNPH1","stoichiometry":0.2},{"gene":"HNRNPL","stoichiometry":0.2},{"gene":"HSP90B1","stoichiometry":0.2},{"gene":"SNRPB","stoichiometry":0.2},{"gene":"SNRPC","stoichiometry":0.2}],"url":"https://opencell.sf.czbiohub.org/search/ZCCHC8","total_profiled":1310},"omim":[{"mim_id":"618674","title":"PULMONARY FIBROSIS AND/OR BONE MARROW FAILURE SYNDROME, TELOMERE-RELATED, 5; PFBMFT5","url":"https://www.omim.org/entry/618674"},{"mim_id":"616381","title":"ZINC FINGER CCHC DOMAIN-CONTAINING PROTEIN 8; ZCCHC8","url":"https://www.omim.org/entry/616381"},{"mim_id":"614742","title":"PULMONARY FIBROSIS AND/OR BONE MARROW FAILURE SYNDROME, TELOMERE-RELATED, 1; PFBMFT1","url":"https://www.omim.org/entry/614742"},{"mim_id":"613713","title":"PCI DOMAIN-CONTAINING PROTEIN 2; PCID2","url":"https://www.omim.org/entry/613713"},{"mim_id":"603137","title":"CULLIN 4A; CUL4A","url":"https://www.omim.org/entry/603137"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Enhanced","locations":[{"location":"Nucleoplasm","reliability":"Enhanced"}],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in all","driving_tissues":[{"tissue":"bone marrow","ntpm":41.2}],"url":"https://www.proteinatlas.org/search/ZCCHC8"},"hgnc":{"alias_symbol":["DKFZp434E2220"],"prev_symbol":[]},"alphafold":{"accession":"Q6NZY4","domains":[{"cath_id":"-","chopping":"53-134_149-198","consensus_level":"medium","plddt":74.5108,"start":53,"end":198},{"cath_id":"-","chopping":"228-273","consensus_level":"medium","plddt":77.7367,"start":228,"end":273},{"cath_id":"-","chopping":"290-330_357-408","consensus_level":"high","plddt":89.0602,"start":290,"end":408}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q6NZY4","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q6NZY4-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q6NZY4-F1-predicted_aligned_error_v6.png","plddt_mean":61.22},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=ZCCHC8","jax_strain_url":"https://www.jax.org/strain/search?query=ZCCHC8"},"sequence":{"accession":"Q6NZY4","fasta_url":"https://rest.uniprot.org/uniprotkb/Q6NZY4.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q6NZY4/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q6NZY4"}},"corpus_meta":[{"pmid":"31488579","id":"PMC_31488579","title":"ZCCHC8, the nuclear exosome targeting component, is mutated in familial pulmonary fibrosis and is required for telomerase RNA maturation.","date":"2019","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/31488579","citation_count":105,"is_preprint":false},{"pmid":"29844170","id":"PMC_29844170","title":"Structural basis for MTR4-ZCCHC8 interactions that stimulate the MTR4 helicase in the nuclear exosome-targeting complex.","date":"2018","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/29844170","citation_count":57,"is_preprint":false},{"pmid":"27905398","id":"PMC_27905398","title":"Structure of the RBM7-ZCCHC8 core of the NEXT complex reveals connections to splicing factors.","date":"2016","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/27905398","citation_count":43,"is_preprint":false},{"pmid":"31747613","id":"PMC_31747613","title":"Nuclear Exosome Targeting Complex Core Factor Zcchc8 Regulates the Degradation of LINE1 RNA in Early Embryos and Embryonic Stem Cells.","date":"2019","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/31747613","citation_count":40,"is_preprint":false},{"pmid":"27121553","id":"PMC_27121553","title":"Identification of ZCCHC8 as fusion partner of ROS1 in a case of congenital glioblastoma multiforme with a t(6;12)(q21;q24.3).","date":"2016","source":"Genes, chromosomes & cancer","url":"https://pubmed.ncbi.nlm.nih.gov/27121553","citation_count":33,"is_preprint":false},{"pmid":"16263084","id":"PMC_16263084","title":"Zcchc8 is a glycogen synthase kinase-3 substrate that interacts with RNA-binding proteins.","date":"2005","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/16263084","citation_count":21,"is_preprint":false},{"pmid":"32671216","id":"PMC_32671216","title":"A COMMON PITUITARY AUTOANTIBODY IN TWO PATIENTS WITH IMMUNE CHECKPOINT INHIBITOR-MEDIATED HYPOPHYSITIS: ZCCHC8.","date":"2020","source":"AACE clinical case reports","url":"https://pubmed.ncbi.nlm.nih.gov/32671216","citation_count":12,"is_preprint":false},{"pmid":"38375433","id":"PMC_38375433","title":"A new variant in the ZCCHC8 gene: diverse clinical phenotypes and expression in the lung.","date":"2024","source":"ERJ open research","url":"https://pubmed.ncbi.nlm.nih.gov/38375433","citation_count":7,"is_preprint":false},{"pmid":"30095326","id":"PMC_30095326","title":"A novel co-existing ZCCHC8-ROS1 and de-novo MET amplification dual driver in advanced lung adenocarcinoma with a good response to crizotinib.","date":"2018","source":"Cancer biology & therapy","url":"https://pubmed.ncbi.nlm.nih.gov/30095326","citation_count":6,"is_preprint":false},{"pmid":"39256642","id":"PMC_39256642","title":"ZCCHC8 p.P410A disrupts nucleocytoplasmic localization, promoting idiopathic pulmonary fibrosis and chronic obstructive pulmonary disease.","date":"2024","source":"Molecular medicine (Cambridge, Mass.)","url":"https://pubmed.ncbi.nlm.nih.gov/39256642","citation_count":5,"is_preprint":false},{"pmid":"39758125","id":"PMC_39758125","title":"Core factor of NEXT complex, ZCCHC8, governs the silencing of LINE1 during spermatogenesis.","date":"2024","source":"National science review","url":"https://pubmed.ncbi.nlm.nih.gov/39758125","citation_count":1,"is_preprint":false},{"pmid":null,"id":"bio_10.1101_2025.08.25.671287","title":"Nuclear exosome targeting complexes modulate cohesin binding and enhancer-promoter interactions in 3D","date":"2025-08-27","source":"bioRxiv","url":"https://doi.org/10.1101/2025.08.25.671287","citation_count":0,"is_preprint":true}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":7912,"output_tokens":2376,"usd":0.029688,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":9490,"output_tokens":3348,"usd":0.065575,"stage2_stop_reason":"end_turn"},"total_usd":0.095263,"stage1_batch_id":"msgbatch_01UT1AahFPCAyn2uVweS7A9z","stage2_batch_id":"msgbatch_01HuKWtKNT4Pqj1bc8eEP5RV","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2018,\n      \"finding\": \"Crystal structure of the ZCCHC8 C-terminal domain bound to the MTR4 helicase core reveals a bipartite interaction that is distinct from yeast exosome cofactors Trf4p/Air2p; this interaction stimulates MTR4 helicase and ATPase activities. RBM7 association with NEXT further enhances MTR4 helicase activity, with uridine-rich substrates preferred by RBM7 and polyadenylated 3' ends optimal for full activity.\",\n      \"method\": \"Crystal structure determination, in vitro helicase/ATPase assays, domain mapping, mutagenesis\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — crystal structure combined with in vitro reconstituted enzymatic assays and mutagenesis in a single rigorous study\",\n      \"pmids\": [\"29844170\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"A proline-rich segment of ZCCHC8 serves as the direct interaction site for the RNA-recognition motif (RRM) of RBM7, as revealed by crystal structure at 2.0 Å resolution, defining how RBM7 is incorporated into the NEXT complex. The same ZCCHC8 proline-rich motif shares structural similarity with splicing factor SAP145, allowing RBM7 to interact with both NEXT and spliceosomal components.\",\n      \"method\": \"Crystal structure (2.0 Å), domain mapping, in vitro binding assays\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — high-resolution crystal structure with functional domain mapping, replicated across two orthogonal binding assays in the same study\",\n      \"pmids\": [\"27905398\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"ZCCHC8 associates with telomerase RNA (TR) and is required for its 3' end maturation; loss of ZCCHC8 causes accumulation of genomically extended TR at the expense of mature TR, consistent with a role in mediating TR 3' end targeting to the nuclear RNA exosome. Heterozygous loss-of-function of ZCCHC8 causes TR insufficiency in both human mutation carriers and heterozygous Zcchc8-null mice.\",\n      \"method\": \"Genome-wide linkage, ZCCHC8 knockout cells, Zcchc8-null mouse model, RNA analysis (TR maturation), association studies\",\n      \"journal\": \"Genes & development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — reciprocal genetic and molecular evidence across human patients and mouse KO model with orthogonal RNA maturation assays\",\n      \"pmids\": [\"31488579\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Zcchc8-null mice show accumulation and 3' end misprocessing of low-abundance RNAs including intronless replication-dependent histone mRNAs and cilia-component RNAs, demonstrating that nuclear exosome targeting via ZCCHC8 is an essential 3' end maturation mechanism shared across these RNA classes.\",\n      \"method\": \"Zcchc8-null mouse model, transcriptome analysis, RNA 3' end sequencing\",\n      \"journal\": \"Genes & development\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — KO mouse with defined transcriptomic phenotype, single lab, RNA-seq as primary readout\",\n      \"pmids\": [\"31488579\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Zcchc8 is required for degradation of LINE1 retrotransposon transcripts in mouse early embryos and embryonic stem cells; Zcchc8-deficient ESCs exhibit proliferation abnormalities and reduced developmental potency, and maternal Zcchc8-depleted oocytes show higher chromatin accessibility and developmental defects, establishing a Zcchc8-mediated RNA degradation mechanism targeting LINE1.\",\n      \"method\": \"Zcchc8 knockout mouse, ESC depletion, RNA quantification, chromatin accessibility assays, developmental phenotyping\",\n      \"journal\": \"Cell reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — clean KO with defined cellular and molecular phenotype, single lab, multiple orthogonal readouts\",\n      \"pmids\": [\"31747613\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"Zcchc8 is directly phosphorylated by GSK-3 in vitro, and GSK-3 inhibition prevents Zcchc8 phosphorylation in vivo. Zcchc8 is a nuclear protein that interacts with RNA processing/degradation proteins.\",\n      \"method\": \"In vitro kinase assay with GSK-3, GSK-3 inhibitor treatment in cells, immunoprecipitation with RNA-binding proteins\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1–2 / Moderate — in vitro kinase assay plus cellular inhibitor validation plus co-IP, single lab, early foundational study\",\n      \"pmids\": [\"16263084\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"A novel ZCCHC8 mutation (p.P410A) disrupts nucleocytoplasmic localization of ZCCHC8, which further decreases expression of DKC1 and RTEL1 and reduces telomere length, linking ZCCHC8 nuclear localization to telomere maintenance.\",\n      \"method\": \"Whole exome sequencing, Sanger sequencing, subcellular localization assay, gene expression analysis, telomere length measurement\",\n      \"journal\": \"Molecular medicine (Cambridge, Mass.)\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 / Weak — localization assay with functional downstream readouts, single lab, single family\",\n      \"pmids\": [\"39256642\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"Loss of ZCCHC8 during spermatogenesis results in upregulation of young LINE1 (L1Md_A) subfamilies in spermatogonial stem cells and pachytene spermatocytes, accompanied by reduced H3K9me3 in SSC and elevated H3K4me3 in pachytene spermatocytes at L1 loci, contributing to impaired chromatin condensation and delayed meiotic progression.\",\n      \"method\": \"Zcchc8 knockout mouse, RNA-seq, ChIP-seq for H3K9me3 and H3K4me3, spermatogenesis phenotyping\",\n      \"journal\": \"National science review\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — KO mouse with ChIP-seq and RNA-seq defining chromatin mechanism, single lab\",\n      \"pmids\": [\"39758125\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"Chromatin recruitment mapping shows ZCCHC8 (NEXT) associates with sites of enhancer-promoter interactions. Depletion of NEXT induces accumulation of ncRNAs (eRNAs and PROMPTs) and increases cohesin levels at those sites, suggesting NEXT-mediated ncRNA degradation influences cohesin binding and 3D enhancer-promoter contacts.\",\n      \"method\": \"ChIP-seq (chromatin recruitment), NEXT depletion, RNA-seq, chromatin conformation capture (3C/Hi-C)\",\n      \"journal\": \"bioRxiv\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — preprint, single lab, indirect evidence linking ZCCHC8 chromatin localization to cohesin/3D genome; primary focus is MTR4 rather than ZCCHC8 specifically\",\n      \"pmids\": [\"bio_10.1101_2025.08.25.671287\"],\n      \"is_preprint\": true\n    }\n  ],\n  \"current_model\": \"ZCCHC8 is a scaffold zinc-knuckle protein that forms the NEXT (nuclear exosome targeting) complex with RBM7 and MTR4, where it bridges RBM7 (via a proline-rich domain) and directly stimulates MTR4 helicase/ATPase activity through its C-terminal domain, thereby targeting aberrant and noncoding RNAs—including telomerase RNA, replication-dependent histone mRNAs, and LINE1 retrotransposon transcripts—for 3' end maturation or degradation by the nuclear RNA exosome; its nuclear localization is functionally required, as disease-associated mutations disrupt this localization and impair telomere maintenance, and it is also a substrate of GSK-3 kinase.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"ZCCHC8 is the scaffold subunit of the nuclear exosome targeting (NEXT) complex, coupling RNA substrate recognition to the catalytic machinery that degrades or matures aberrant and noncoding nuclear RNAs [#0, #1]. A proline-rich segment of ZCCHC8 directly engages the RNA-recognition motif of RBM7, incorporating it into NEXT, while structural mimicry of the splicing factor SAP145 by this motif allows RBM7 to partition between NEXT and spliceosomal components [#1]. Through a bipartite C-terminal interaction with the MTR4 helicase core, ZCCHC8 directly stimulates MTR4 helicase and ATPase activities, with RBM7 association further enhancing activity on uridine-rich and polyadenylated substrates [#0]. Functionally, ZCCHC8 directs 3' end maturation and degradation of diverse RNA classes by the nuclear RNA exosome, including telomerase RNA, intronless replication-dependent histone mRNAs, and LINE1 retrotransposon transcripts [#2, #3, #4]. Loss of ZCCHC8 causes accumulation of genomically extended telomerase RNA at the expense of mature TR, and heterozygous loss-of-function produces TR insufficiency in human carriers and mice [#2]; a localization-disrupting mutation lowers DKC1 and RTEL1 expression and shortens telomeres, linking ZCCHC8 nuclear localization to telomere maintenance [#6]. Beyond RNA turnover, ZCCHC8-mediated LINE1 degradation shapes the chromatin landscape during early development and spermatogenesis [#4, #7], and ZCCHC8 is directly phosphorylated by GSK-3 [#5].\",\n  \"teleology\": [\n    {\n      \"year\": 2005,\n      \"claim\": \"Established ZCCHC8 as a nuclear protein physically associated with RNA processing/degradation machinery and a direct kinase substrate, providing the first functional context before NEXT was defined.\",\n      \"evidence\": \"In vitro GSK-3 kinase assay, cellular GSK-3 inhibition, and co-IP with RNA-binding proteins\",\n      \"pmids\": [\"16263084\"],\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"\",\n      \"gaps\": [\"Specific phosphosites and the functional consequence of GSK-3 phosphorylation not defined\", \"Identity of the associated RNA-processing partners not resolved at molecular level\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Resolved how RBM7 is recruited into NEXT, showing ZCCHC8 acts as the structural bridge for substrate-recognition subunits.\",\n      \"evidence\": \"2.0 Å crystal structure of the ZCCHC8 proline-rich segment bound to the RBM7 RRM, with domain mapping and in vitro binding\",\n      \"pmids\": [\"27905398\"],\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"\",\n      \"gaps\": [\"Does not address how the assembled complex selects in vivo RNA substrates\", \"Functional consequence of the SAP145 mimicry / spliceosome crosstalk not tested in cells\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Defined the catalytic coupling of NEXT, showing ZCCHC8 directly activates the exosome helicase rather than merely tethering it.\",\n      \"evidence\": \"Crystal structure of the ZCCHC8 C-terminal domain bound to the MTR4 helicase core, with reconstituted in vitro helicase/ATPase assays and mutagenesis\",\n      \"pmids\": [\"29844170\"],\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"\",\n      \"gaps\": [\"In vitro substrate preferences may not capture full physiological substrate range\", \"How ZCCHC8 stimulation is regulated in the cell is unknown\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Connected the molecular machinery to physiology, establishing ZCCHC8 as required for telomerase RNA 3' end maturation and as a disease-relevant cause of TR insufficiency.\",\n      \"evidence\": \"Human linkage/mutation carriers, Zcchc8-null mice, knockout cells, and RNA maturation assays\",\n      \"pmids\": [\"31488579\"],\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"\",\n      \"gaps\": [\"Mechanism by which extended TR is selectively recognized vs other substrates not dissected\", \"Clinical penetrance/spectrum from heterozygous loss not fully mapped\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Generalized ZCCHC8 function beyond telomerase RNA, showing it mediates 3' end processing of multiple low-abundance RNA classes.\",\n      \"evidence\": \"Zcchc8-null mouse transcriptome and RNA 3' end sequencing of histone and cilia-component RNAs\",\n      \"pmids\": [\"31488579\"],\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"\",\n      \"gaps\": [\"Single-lab transcriptomic readout\", \"Direct vs indirect effects on each RNA class not separated\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Identified a developmental role through targeted degradation of LINE1 transcripts, linking RNA surveillance to chromatin state and developmental potency.\",\n      \"evidence\": \"Zcchc8 knockout mice, ESC depletion, RNA quantification, chromatin accessibility assays, developmental phenotyping\",\n      \"pmids\": [\"31747613\"],\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"\",\n      \"gaps\": [\"Whether LINE1 effects are entirely exosome-dependent not established\", \"Single-lab phenotype\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Demonstrated that nuclear localization of ZCCHC8 is functionally required for telomere maintenance, tying a specific mutation to downstream telomere-pathway gene expression.\",\n      \"evidence\": \"Whole exome/Sanger sequencing of a family, subcellular localization assay, DKC1/RTEL1 expression and telomere length measurement\",\n      \"pmids\": [\"39256642\"],\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"\",\n      \"gaps\": [\"Single family, single lab\", \"Mechanism linking mislocalization to reduced DKC1/RTEL1 expression unresolved\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Extended the LINE1-surveillance role to meiosis, showing ZCCHC8 loss derepresses young LINE1 and alters histone marks, impairing spermatogenesis.\",\n      \"evidence\": \"Zcchc8 knockout mouse, RNA-seq, ChIP-seq for H3K9me3 and H3K4me3, spermatogenesis phenotyping\",\n      \"pmids\": [\"39758125\"],\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"\",\n      \"gaps\": [\"Causal link between RNA derepression and the observed histone changes not fully separated\", \"Single-lab study\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Proposed a role for NEXT/ZCCHC8 in 3D genome organization via ncRNA degradation affecting cohesin and enhancer-promoter contacts.\",\n      \"evidence\": \"ChIP-seq chromatin recruitment, NEXT depletion with RNA-seq, and chromatin conformation capture (preprint)\",\n      \"pmids\": [\"bio_10.1101_2025.08.25.671287\"],\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"\",\n      \"gaps\": [\"Preprint, not peer-reviewed; primary focus on MTR4 rather than ZCCHC8\", \"Indirect link between ncRNA degradation and cohesin/3D contacts\", \"ZCCHC8-specific contribution not isolated\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How ZCCHC8 substrate selectivity is governed across its diverse RNA targets, and how post-translational regulation (e.g. GSK-3 phosphorylation) and chromatin recruitment integrate with NEXT activity, remain open.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"\",\n      \"gaps\": [\"No unified model of substrate discrimination among TR, histone mRNAs, and LINE1\", \"Functional consequence of GSK-3 phosphorylation undefined\", \"Chromatin-recruitment mechanism unconfirmed in peer-reviewed work\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0003723\", \"supporting_discovery_ids\": [0, 2, 5]},\n      {\"term_id\": \"GO:0060090\", \"supporting_discovery_ids\": [0, 1]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [0]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [5, 6]},\n      {\"term_id\": \"GO:0005694\", \"supporting_discovery_ids\": [7]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-8953854\", \"supporting_discovery_ids\": [0, 2, 3, 4]}\n    ],\n    \"complexes\": [\"NEXT (nuclear exosome targeting) complex\"],\n    \"partners\": [\"RBM7\", \"MTR4\", \"GSK-3\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":6,"faith_total":6,"faith_pct":100.0}}